Biolife Solutions (BLFS) Debt to Equity (2016 - 2025)
Historic Debt to Equity for Biolife Solutions (BLFS) over the last 13 years, with Q3 2025 value amounting to $0.02.
- Biolife Solutions' Debt to Equity fell 6562.74% to $0.02 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.02, marking a year-over-year decrease of 6562.74%. This contributed to the annual value of $0.05 for FY2024, which is 3530.9% down from last year.
- Per Biolife Solutions' latest filing, its Debt to Equity stood at $0.02 for Q3 2025, which was down 6562.74% from $0.03 recorded in Q2 2025.
- Biolife Solutions' Debt to Equity's 5-year high stood at $0.08 during Q3 2023, with a 5-year trough of $0.02 in Q1 2021.
- For the 5-year period, Biolife Solutions' Debt to Equity averaged around $0.05, with its median value being $0.05 (2024).
- As far as peak fluctuations go, Biolife Solutions' Debt to Equity crashed by 9393.12% in 2021, and later skyrocketed by 28077.3% in 2023.
- Quarter analysis of 5 years shows Biolife Solutions' Debt to Equity stood at $0.02 in 2021, then surged by 196.5% to $0.07 in 2022, then dropped by 0.82% to $0.07 in 2023, then crashed by 35.31% to $0.05 in 2024, then plummeted by 53.64% to $0.02 in 2025.
- Its Debt to Equity was $0.02 in Q3 2025, compared to $0.03 in Q2 2025 and $0.04 in Q1 2025.